DK1290011T3 - Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler - Google Patents

Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler

Info

Publication number
DK1290011T3
DK1290011T3 DK01938945.1T DK01938945T DK1290011T3 DK 1290011 T3 DK1290011 T3 DK 1290011T3 DK 01938945 T DK01938945 T DK 01938945T DK 1290011 T3 DK1290011 T3 DK 1290011T3
Authority
DK
Denmark
Prior art keywords
chemotherapeutic drugs
cancer chemotherapeutic
melphalan
melphalan derivatives
derivatives
Prior art date
Application number
DK01938945.1T
Other languages
Danish (da)
English (en)
Inventor
Rolf Larsson
Rolf Lewensohn
Joakim Gullbo
Hans Ehrsson
Kristina Luthman
Original Assignee
Oncopeptides Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncopeptides Ab filed Critical Oncopeptides Ab
Application granted granted Critical
Publication of DK1290011T3 publication Critical patent/DK1290011T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01938945.1T 2000-06-13 2001-06-11 Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler DK1290011T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21122700P 2000-06-13 2000-06-13
SE0002202A SE0002202D0 (sv) 2000-06-13 2000-06-13 New peptides
PCT/SE2001/001318 WO2001096367A1 (en) 2000-06-13 2001-06-11 Melphalan derivatives and their use as cancer chemotherapeutic drugs

Publications (1)

Publication Number Publication Date
DK1290011T3 true DK1290011T3 (da) 2010-06-07

Family

ID=20280067

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01938945.1T DK1290011T3 (da) 2000-06-13 2001-06-11 Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler

Country Status (10)

Country Link
EP (1) EP1290011B1 (enExample)
JP (1) JP4798930B2 (enExample)
AT (1) ATE458746T1 (enExample)
AU (1) AU2001264515A1 (enExample)
CA (1) CA2408501C (enExample)
DK (1) DK1290011T3 (enExample)
ES (1) ES2341702T3 (enExample)
PT (1) PT1290011E (enExample)
SE (1) SE0002202D0 (enExample)
WO (1) WO2001096367A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1374907A3 (en) * 2002-06-24 2004-01-07 Ghanem Elias c/o Institut Jules Bordet Ghanem Drug transport and delivery system
DE10239832A1 (de) * 2002-08-29 2004-03-18 Lipal Biochemicals AG c/o University of Zurich Sarcolysyl-Derivate und Verfahren zu deren Herstellung
WO2011011865A1 (en) * 2009-07-29 2011-02-03 3R Valo, S.E.C. Anticancer agents based on amino acid derivatives
WO2011078782A1 (en) * 2009-12-22 2011-06-30 Oncopeptides Ab A composition comprising of melphalan derivatives and gemcitabine or etoposide useful in the treatment of cancer
DK2701720T3 (en) * 2011-04-28 2017-10-09 Oncopeptides Ab Lyophilized preparation with cytotoxic dipeptides
KR102122429B1 (ko) * 2011-04-28 2020-06-12 온코펩타이드즈 아베 세포독성 디펩티드의 동결건조 제제
KR102226082B1 (ko) * 2012-10-26 2021-03-10 온코펩타이드즈 아베 멜팔란 플루펜아미드의 동결건조 제제
SMT202000058T1 (it) 2012-10-26 2020-03-13 Oncopeptides Ab Preparazioni liofilizzate di melfalan flufenammide
GB201507903D0 (en) 2015-05-08 2015-06-24 Oncopeptides Ab Process for preparation of nitrogen mustard derivatives
GB201521217D0 (en) 2015-12-01 2016-01-13 Oncopeptides Ab Dosage regimens
CN108864251B (zh) * 2018-06-30 2022-06-14 大连理工大学 一类氨肽酶n激活的药物前体化合物及其制备方法和应用
US12152087B2 (en) 2018-10-18 2024-11-26 Oncopeptides Innovation Ab Deuterated melflufen compounds
WO2020201542A1 (en) 2019-04-03 2020-10-08 Oncopeptides Ab Treatment of al amyloidosis with melflufen
GB201905477D0 (en) * 2019-04-17 2019-05-29 Oncopeptides Ab Novel formulations
WO2021053185A1 (en) 2019-09-20 2021-03-25 Oncopeptides Ab Melflufen formulations and their use in the treatment or prophylaxis of osteosarcoma
WO2022167087A1 (en) * 2021-02-05 2022-08-11 Oncopeptides Ab Peptidase enhanced cytotoxic dipeptides
EP4083052A1 (en) 2021-04-29 2022-11-02 BKmdcl AB Peptide conjugates of melphalan for the treatment of cancer
ES3034388T3 (en) 2021-06-01 2025-08-18 Synthon Bv Process for making melflufen or a salt thereof
GB202109894D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
GB202109895D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
JP2024524552A (ja) 2021-07-08 2024-07-05 オンコペプティデス エービー 多発性骨髄腫の治療に使用するためのメルフルフェン
GB202109896D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
GB202204171D0 (en) 2022-03-24 2022-05-11 Oncopeptides Ab Novel formulations
WO2026057823A1 (en) 2024-09-13 2026-03-19 Oncopeptides Ab Bis-chloroethylamino derivatives for treating leukemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB750155A (en) 1953-03-17 1956-06-13 Nat Res Dev Substituted alanines

Also Published As

Publication number Publication date
CA2408501A1 (en) 2001-12-20
EP1290011A1 (en) 2003-03-12
CA2408501C (en) 2011-01-18
EP1290011B1 (en) 2010-02-24
PT1290011E (pt) 2010-05-11
ES2341702T3 (es) 2010-06-25
WO2001096367A1 (en) 2001-12-20
JP2004503564A (ja) 2004-02-05
SE0002202D0 (sv) 2000-06-13
JP4798930B2 (ja) 2011-10-19
ATE458746T1 (de) 2010-03-15
AU2001264515A1 (en) 2001-12-24

Similar Documents

Publication Publication Date Title
DK1290011T3 (da) Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler
DK1178958T3 (da) N-cyanomethylamider som proteaseinhibitorer
TW200711657A (en) Pharmaceutical composition comprising botulinum toxin and recombinant human serum albumin
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
BR0107147A (pt) Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
NO20025358L (no) Ortosubstituerte antranilsyreamider og deres anvendelse som legemidler
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
NO992102L (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
BR0014378A (pt) Derivados de ácido indolil-3-glioxìlico tendo propriedades terapeuticamente valiosas
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
CY1105008T1 (el) Αντιμικροβιακη ενεργοτητα του πρωτου κατιονικου συγκροτηματος της ανθρωπινης λακτοφερρινης
WO2006050930A3 (en) Conjugates with enhanced cell uptake activity
NO20026147L (no) Trombomodulinanaloger for farmasoytisk anvendelse
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca
WO2005002500A3 (en) Inhibitors of coronavirus
BR0109279A (pt) Antagonistas de lhrh, sua preparação e aplicação como medicamento
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
AU3739500A (en) Protease resistant flint analogs
WO2003092736A3 (en) Peptide nucleic acid conjugates with transporter peptides
BR0316029A (pt) Combinação
SE0203817D0 (sv) New composition
ATE241640T1 (de) Fusidinsäure-derivate
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
WO2003066806A3 (en) Therapeutic use of aziridino compounds